Andreas Niederquell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Andreas Niederquell has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Martin Kuentz
School of Life Sciences, University of Applied Sciences and Arts Northwestern Switzerland, CH 4132 Muttenz, Switzerland
7 shared publications - Barbora Vraníková
Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
4 shared publications - Zdenka Šklubalová
Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
3 shared publications - Anette Müllertz
Department of Pharmacy, University of Copenhagen, Universitetsparken 2, Copenhagen 2100, Denmark; Bioneer A/S, Kogle Allé 2, Hørsholm 2970, Denmark
1 shared publication Annika Hofer
Institute for Pharma Technology, University of Applied Sciences and Arts Northwestern Switzerland, School of Life Sciences FHNW, Hofackerstr. 30, 4132 Muttenz, Switzerland
1 shared publicationBarbora Vraníková
Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
1 shared publication
Latest Publications
- Open Access
- 23 September 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 214, 107283
Approaching drug release performance from mesoporous silica formulations by modeling of chemical potentials
- 23 September 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 214, 107283
Open AccessApproaching drug release performance from mesoporous silica formulations by modeling of chemical potentials
- Open Access
- 2 July 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 682, 125918
Ranking of apparent drug affinity to mesoporous silica utilizing a chromatographic screening method and a tree-based prediction model
- 2 July 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 682, 125918
Open AccessRanking of apparent drug affinity to mesoporous silica utilizing a chromatographic screening method and a tree-based prediction model
- 10 December 2023
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 650, 123702
Comparison of the liquisolid technique and co-milling for loading of a poorly soluble drug in inorganic porous excipients
- 10 December 2023
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 650, 123702
Comparison of the liquisolid technique and co-milling for loading of a poorly soluble drug in inorganic porous excipients
- 10 January 2022
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 19 (2) , 690-703
Hydroxypropyl Cellulose for Drug Precipitation Inhibition: From the Potential of Molecular Interactions to Performance Considering Microrheology
There has been recent interest in using hydroxypropyl cellulose (HPC) for supersaturating drug formulations. This study investigated the potential for molecular HPC interactions with the model drug celecoxib by integrating novel approaches in the field of drug supersaturation analysis. Following an initial polymer characterization study, quantum-chemical calculations and molecular dynamics simulations were complemented with results of inverse gas chromatography and broadband diffusing wave spectroscopy. HPC performance was studied regarding drug solubilization and kinetics of desupersaturation using different grades (i.e., HPC-UL, SSL, SL, and L). The results suggested that the potential contribution of dispersive interactions and hydrogen bonding depended strongly on the absence or presence of the aqueous phase. It was proposed that aggregation of HPC polymer chains provided a complex heterogeneity of molecular environments with more or less excluded water for drug interaction. In precipitation experiments at a low aqueous polymer concentration (i.e., 0.01%, w/w), grades L and SL appeared to sustain drug supersaturation better than SSL and UL. However, UL was particularly effective in drug solubilization at pH 6.8. Thus, a better understanding of drug–polymer interactions is important for formulation development, and polymer blends may be used to harness the combined advantages of individual polymer grades.
- 10 January 2022
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 19 (2) , 690-703
Hydroxypropyl Cellulose for Drug Precipitation Inhibition: From the Potential of Molecular Interactions to Performance Considering Microrheology
There has been recent interest in using hydroxypropyl cellulose (HPC) for supersaturating drug formulations. This study investigated the potential for molecular HPC interactions with the model drug celecoxib by integrating novel approaches in the field of drug supersaturation analysis. Following an initial polymer characterization study, quantum-chemical calculations and molecular dynamics simulations were complemented with results of inverse gas chromatography and broadband diffusing wave spectroscopy. HPC performance was studied regarding drug solubilization and kinetics of desupersaturation using different grades (i.e., HPC-UL, SSL, SL, and L). The results suggested that the potential contribution of dispersive interactions and hydrogen bonding depended strongly on the absence or presence of the aqueous phase. It was proposed that aggregation of HPC polymer chains provided a complex heterogeneity of molecular environments with more or less excluded water for drug interaction. In precipitation experiments at a low aqueous polymer concentration (i.e., 0.01%, w/w), grades L and SL appeared to sustain drug supersaturation better than SSL and UL. However, UL was particularly effective in drug solubilization at pH 6.8. Thus, a better understanding of drug–polymer interactions is important for formulation development, and polymer blends may be used to harness the combined advantages of individual polymer grades.
- 1 December 2020
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 591, 120019
Relevance of the theoretical critical pore radius in mesoporous silica for fast crystallizing drugs
- 1 December 2020
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 591, 120019
Relevance of the theoretical critical pore radius in mesoporous silica for fast crystallizing drugs
- 1 March 2020
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 578, 119099
Mechanistic aspects of drug loading in liquisolid systems with hydrophilic lipid-based mixtures
- 1 March 2020
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 578, 119099
Mechanistic aspects of drug loading in liquisolid systems with hydrophilic lipid-based mixtures
- Open Access
- 4 January 2019
- Published by MDPI AG in Pharmaceutics
- Vol. 11 (1) , 17
Partial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics
Partial solvation parameters (PSP) have much in common with the Hansen solubility parameter or with a linear solvation energy relationship (LSER), but there are advantages based on the sound thermodynamic basis. It is, therefore, surprising that PSP has so far not been harnessed in pharmaceutics for the selection of excipients or property estimation of formulations and their components. This work introduces PSP calculation for drugs, where the raw data were obtained from inverse gas chromatography. It was shown that only a few probe gases were needed to get reasonable estimates of the drug PSPs. Interestingly, an alternative calculation of LSER parameters in silico did not reflect the experimentally obtained activity coefficients for all probe gases as well, which was attributed to the complexity of the drug structures. The experimental PSPs were proven to be helpful in predicting drug solubility in various solvents and the PSP framework allowed calculation of the different surface energy contributions. A specific benefit of PSP is that parameters can be readily converted to either classical solubility or LSER parameters. Therefore, PSP is not just about a new definition of solvatochromic parameters, but the underlying thermodynamics provides a unified approach, which holds much promise for broad applications in pharmaceutics.
- 4 January 2019
- Published by MDPI AG in Pharmaceutics
- Vol. 11 (1) , 17
Open AccessPartial Solvation Parameters of Drugs as a New Thermodynamic Tool for Pharmaceutics
Partial solvation parameters (PSP) have much in common with the Hansen solubility parameter or with a linear solvation energy relationship (LSER), but there are advantages based on the sound thermodynamic basis. It is, therefore, surprising that PSP has so far not been harnessed in pharmaceutics for the selection of excipients or property estimation of formulations and their components. This work introduces PSP calculation for drugs, where the raw data were obtained from inverse gas chromatography. It was shown that only a few probe gases were needed to get reasonable estimates of the drug PSPs. Interestingly, an alternative calculation of LSER parameters in silico did not reflect the experimentally obtained activity coefficients for all probe gases as well, which was attributed to the complexity of the drug structures. The experimental PSPs were proven to be helpful in predicting drug solubility in various solvents and the PSP framework allowed calculation of the different surface energy contributions. A specific benefit of PSP is that parameters can be readily converted to either classical solubility or LSER parameters. Therefore, PSP is not just about a new definition of solvatochromic parameters, but the underlying thermodynamics provides a unified approach, which holds much promise for broad applications in pharmaceutics.
- 1 July 2018
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 546 (1-2) , 137-144
New prediction methods for solubility parameters based on molecular sigma profiles using pharmaceutical materials
- 1 July 2018
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 546 (1-2) , 137-144
New prediction methods for solubility parameters based on molecular sigma profiles using pharmaceutical materials